Posted by Michael Wonder on 30 Mar 2020
Trump administration in talks with India to avoid U.S. drug supply shortage
31 March 2020 - India, the top source of generic drugs and ingredients, has restricted exports but the U.S. wants exemptions to have enough to fight coronavirus.
Trump administration officials are asking India to lift restrictions to give the U.S. access to pharmaceutical ingredients needed to produce a range of drugs, amid fears of a potential U.S. drug supply shortage prompted by the coronavirus outbreak, three sources familiar with the matter told NBC News.
The two governments are holding discussions aimed at easing newly imposed restrictions on pharmaceutical exports from India, which Delhi introduced to ensure the country would have medicine needed to handle the pandemic inside of its borders, the sources said.
